Abstract
Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have